Program - Alpha-Synuclein in Parkinson’s Disease and Disease-Modifying Strategies for Non-Motor Symptoms

Alpha-Synuclein in Parkinson’s Disease and Disease-Modifying Strategies for Non-Motor Symptoms

Tracks

MC 2 Hall

Monday, June 24, 2024

4:15 PM - 5:45 PM

MC2 Hall

Overview

Organized by the Turkish Pharmacological Society

Speaker

Prof. Leonidas Stefanis

National and Kapodistrian University of Athens Medical School

Alpha synuclein as a therapeutic target in Parkinson's Disease and related synucleinopathies

4:15 PM - 4:45 PM

Prof. Banu Cahide Tel

Hacettepe University

Modeling non-motor symptoms of alpha-synucleinopathy targeting autophagic pathway with rapamycin

4:45 PM - 5:15 PM

Dr. Caroline Biojone

Aarhus University

Uncovering a new molecular brake of neuronal plasticity: the role of nitric oxide and TRKB signaling

5:15 PM - 5:45 PM

Chair

Nezahat Tuğba Durlu-Kandilci

Hacettepe University

Leonidas Stefanis

National and Kapodistrian University of Athens Medical School

You need to enable JavaScript to access this site.

Follow these instructions on how to enable JavaScript.

Internet Explorer

Select Tools from the top menu
Choose Internet Options
Click on the Security tab
Click on Custom Level
Scroll down until you see the section labelled Scripting
Under Active Scripting, select Enable and click OK

Google Chrome

Select the menu icon on the browser toolbar
Select Settings
Click the Show advanced settings... link then Content Settings in the Privacy section
Select Allow all sites to run JavaScript (recommended) and click Done

Safari (Mac)

Select Safari from the top menu
Choose Preferences
Choose Security
Select the checkbox next to Enable JavaScript